<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Fevertree Drinks Plc — News on 6ix</title>
<link>https://6ix.com/company/fevertree-drinks-plc</link>
<description>Latest news and press releases for Fevertree Drinks Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 16:35:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/fevertree-drinks-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57e5cbeedb30cb6f899a1.webp</url>
<title>Fevertree Drinks Plc</title>
<link>https://6ix.com/company/fevertree-drinks-plc</link>
</image>
<item>
<title>Dividend Timetable Update</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/dividend-timetable-update-1</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/dividend-timetable-update-1</guid>
<pubDate>Tue, 21 Apr 2026 16:35:00 GMT</pubDate>
<description>Fevertree Drinks plc has issued a correction regarding its final dividend timetable, clarifying that the dividend, subject to AGM approval on June 9, 2026, will be paid on June 26, 2026, to shareholders on the register as of May 22, 2026, aligning with previous announcements and other sections of the Annual Report. All other dividend details remain unchanged.
Disclaimer*</description>
</item>
<item>
<title>2025 Annual Report and Notice of AGM</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/2025-annual-report-and-notice-of-agm-8</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/2025-annual-report-and-notice-of-agm-8</guid>
<pubDate>Mon, 20 Apr 2026 16:11:00 GMT</pubDate>
<description>Fevertree Drinks plc has announced the release of its 2025 Annual Report and Notice of Annual General Meeting, which has been posted to shareholders and is available on the company's website. The Annual General Meeting is scheduled to take place on June 9, 2026, at 11:00 a.m. at the company's offices. Shareholders planning to attend in person are encouraged to notify the company in advance via email to assist with arrangements.
Disclaimer*</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/transaction-in-own-shares-781</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/transaction-in-own-shares-781</guid>
<pubDate>Tue, 14 Apr 2026 06:00:00 GMT</pubDate>
<description>Fevertree Drinks plc has announced the purchase of 127,130 ordinary shares between April 7th and April 10th, 2026, as part of its share buyback program. The volume-weighted average purchase price ranged from 769.06 pence to 817.03 pence per share, with individual transactions occurring on XLON and AIMX. The company intends to cancel these repurchased shares, which were acquired under the authority granted by shareholders at the 2025 Annual General Meeting.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/total-voting-rights-924</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/total-voting-rights-924</guid>
<pubDate>Wed, 01 Apr 2026 10:02:00 GMT</pubDate>
<description>Fevertree Drinks plc has announced its total voting rights, stating that its issued share capital consists of 115,205,913 ordinary shares of 0.25p each, with each share carrying one voting right. The company holds no shares in treasury, resulting in a total of 115,205,913 voting rights. This figure serves as the denominator for shareholders to calculate any required notifications regarding their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.
D</description>
</item>
<item>
<title>FY25 Preliminary Results to 31 December 2025</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/fy25-preliminary-results-to-31-december-2025</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/fy25-preliminary-results-to-31-december-2025</guid>
<pubDate>Tue, 24 Mar 2026 07:00:00 GMT</pubDate>
<description>Fevertree Drinks plc reported positive strategic progress for the year ending December 31, 2025, with Adjusted Fever-Tree brand revenue increasing by 4% year-on-year at constant currency to £372.7 million, driven by a 5% acceleration in the second half. The company's diversification strategy is gaining scale, with 45% of Group revenue now generated from products beyond tonic. Despite a 16% year-on-year decrease in Adjusted EBITDA to £42.4 million, partly due to the US transition costs, the compa</description>
</item>
<item>
<title>Commencement of share buyback programme</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/commencement-of-share-buyback-programme-35</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/commencement-of-share-buyback-programme-35</guid>
<pubDate>Mon, 02 Feb 2026 07:00:00 GMT</pubDate>
<description>Fevertree Drinks PLC has commenced a share buyback programme with a maximum consideration of £30 million, which will run until December 31, 2026, with the intention to cancel all repurchased shares to reduce share capital. The company has entered into a non-discretionary agreement with Investec Bank plc to execute these purchases, adhering to regulatory requirements and existing shareholder authorities.
Disclaimer*</description>
</item>
<item>
<title>Pre-close trading update</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/pre-close-trading-update-139</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/pre-close-trading-update-139</guid>
<pubDate>Thu, 29 Jan 2026 07:00:00 GMT</pubDate>
<description>Fever-Tree Drinks plc anticipates its 2025 financial performance to be marginally ahead of market expectations, with adjusted revenue and adjusted EBITDA expected to exceed forecasts. The company reported 5% revenue growth for the Fever-Tree brand in the second half of 2025, contributing to a full-year constant currency growth of 4%. The US market showed a 6% constant currency revenue increase, supported by the transition to Molson Coors' distribution network, while the UK saw a 2% decline. Foll</description>
</item>
<item>
<title>Retirement of Non-Executive Director</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/retirement-of-non-executive-director-12</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/retirement-of-non-executive-director-12</guid>
<pubDate>Mon, 15 Dec 2025 07:00:00 GMT</pubDate>
<description>Fevertree Drinks plc announced that Jeff Popkin will retire as a Non-Executive Director on December 31, 2025, after eight years of service, during which he significantly contributed to the company's growth and international expansion, particularly in the US market. The Chairman expressed gratitude for his valuable insight and expertise.
Disclaimer*</description>
</item>
<item>
<title>Block Listing Return</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/block-listing-return-44</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/block-listing-return-44</guid>
<pubDate>Tue, 02 Dec 2025 11:39:00 GMT</pubDate>
<description>Fevertree Drinks plc has filed a block listing return for its Long Term Incentive Plan and Savings Related Share Option Scheme covering the period from June 1, 2025, to December 1, 2025. At the start of this period, there were 1,147,073 unallotted securities under the Long Term Incentive Plan and 100,000 under the Savings Related Share Option Scheme. During this period, 133,127 securities were issued under the Long Term Incentive Plan and 10,884 under the Savings Related Share Option Scheme, lea</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/holdings-in-company-1236</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/holdings-in-company-1236</guid>
<pubDate>Thu, 27 Nov 2025 15:33:00 GMT</pubDate>
<description>FIL Limited has notified Fevertree Drinks PLC of a change in its major holding, crossing a threshold on November 25, 2025. Following this acquisition or disposal, FIL Limited now holds a total of 5.075500% of voting rights, comprising 1.965500% attached to shares and 3.110000% through financial instruments, specifically CFDs with cash settlement. This represents a total of 5,899,152 voting rights.
Disclaimer*</description>
</item>
<item>
<title>Share Premium Cancellation Confirmation</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/share-premium-cancellation-confirmation</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/share-premium-cancellation-confirmation</guid>
<pubDate>Thu, 13 Nov 2025 15:32:00 GMT</pubDate>
<description>Fevertree Drinks plc has confirmed the effective cancellation of its share premium account, a process sanctioned by the High Court of England and Wales on November 11, 2025, and registered by the Registrar of Companies on November 13, 2025. This cancellation, approved by shareholders on October 17, 2025, does not alter the rights attached to ordinary shares or the total number of shares in issue.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/directorpdmr-shareholding-1107</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/directorpdmr-shareholding-1107</guid>
<pubDate>Mon, 20 Oct 2025 14:35:00 GMT</pubDate>
<description>On October 20, 2025, Fevertree Drinks plc announced that Kevin Havelock, Senior Independent Non-Executive Director, purchased 55,000 ordinary shares in the company on October 16, 2025. The shares were acquired at an average price of GBP 8.68 per share through the London Stock Exchange. This transaction represents an initial notification of a transaction by a person discharging managerial responsibilities. The ordinary shares are of 0.25p each with identification code GB00BRJ9BJ26.
</description>
</item>
<item>
<title>Results of General Meeting</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/results-of-general-meeting-117</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/results-of-general-meeting-117</guid>
<pubDate>Fri, 17 Oct 2025 12:19:00 GMT</pubDate>
<description>Fevertree Drinks PLC announced that at the General Meeting held on October 17, 2025, the special resolution proposed in the Notice of General Meeting was duly passed on a poll.
Disclaimer*</description>
</item>
<item>
<title>TR-1: Notification of major holdings</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/tr-1-notification-of-major-holdings-225</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/tr-1-notification-of-major-holdings-225</guid>
<pubDate>Wed, 01 Oct 2025 14:06:00 GMT</pubDate>
<description>Molson Coors Beverage Company's voting rights in Fevertree Drinks PLC have increased, crossing a threshold on August 1, 2025. The company's total voting rights attached to shares now stand at 9.06%, representing 10,856,628 voting rights. This is an increase from the previously notified position of 8.50%. The notification was made by the issuer on October 1, 2025. Based on the total voting rights published by Fevertree Drinks PLC, Molson Coors Beverage Company held 9.26% of voting rights attached</description>
</item>
<item>
<title>Proposed Share Premium Cancellation</title>
<link>https://6ix.com/company/fevertree-drinks-plc/news/proposed-share-premium-cancellation-1</link>
<guid isPermaLink="true">https://6ix.com/company/fevertree-drinks-plc/news/proposed-share-premium-cancellation-1</guid>
<pubDate>Thu, 11 Sep 2025 07:00:00 GMT</pubDate>
<description>Fevertree Drinks PLC announced a proposed cancellation of its share premium account to create further distributable reserves. This will support potential share buybacks, future dividend payments to shareholders, and other corporate purposes. The Share Premium Cancellation is conditional on shareholder approval at a General Meeting on October 17, 2025, and court approval expected around November 11, 2025. The Effective Date is anticipated on or around November 12, 2025, pending court confirmation</description>
</item>
</channel>
</rss>